The Symbiotec Pharmalab IPO plans to channel Rs 112.50 crore towards the prepayment and/or repayment, fully or partially, of select outstanding borrowings, helping strengthen the company’s balance sheet and potentially reduce its debt burden.
The Symbiotec Pharmalab IPO plans to channel Rs 112.50 crore towards the prepayment and/or repayment, fully or partially, of select outstanding borrowings, helping strengthen the company’s balance sheet and potentially reduce its debt burden.
<iframe src="https://hindustansphere.com/embed/cluster/7f0268b62c97dfe6df5af317bc641af7f482a6f9" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Symbiotec Pharmalab shares to list today; GMP signals 19% listing gain"></iframe>
